|Issuer:||RELMADA THERAPEUTICS, INC. (RLMD)|
|Original Submission Date:|
KELLY PAUL EDWARD
C/O RELMADA THERAPEUTICS, INC.
880 THIRD AVENUE, 12TH FLOOR NEW YORK,, NY 10022
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|WARRANT||2.25||2019-05-14||deemed execution date||P||50,000 (a)||2019-05-14||2024-05-14||common stock 50,000||$2.25||50,000||direct|